Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
0.500 |
2 |
1
|
2018 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
0.500 |
2 |
1
|
2018 |
2019 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.040 |
None |
1.000 |
4 |
1
|
2008 |
2011 |
Graves Disease
|
disease |
Eye Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
585
|
352
|
0.120 |
None |
1.000 |
3 |
2
|
2015 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.130 |
None |
1.000 |
3 |
1
|
2008 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2017 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2017 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.110 |
None |
1.000 |
2 |
1
|
2014 |
2014 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
7
|
2009 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
7
|
2009 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
2 |
7
|
2009 |
2010 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
7
|
2009 |
2010 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
143
|
29
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.100 |
None |
1.000 |
2 |
5
|
2007 |
2009 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.100 |
None |
1.000 |
2 |
1
|
2009 |
2019 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Childhood Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2208
|
151
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |